Results 81 to 90 of about 8,844 (171)

Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax

open access: yesBMC Infectious Diseases, 2018
Background Disease caused by Bacillus anthracis is often accompanied by high mortality primarily due to toxin-mediated injury. In the early disease course, anthrax toxins are secreted; thus, antibiotic use is limited to the early stage.
Qi Tang   +7 more
doaj   +1 more source

Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination

open access: yesToxins, 2015
The interaction of anthrax toxin or toxin components with B. anthracis spores has been demonstrated. Germinating spores can produce significant amounts of toxin components very soon after the initiation of germination.
Christopher K. Cote, Susan L. Welkos
doaj   +1 more source

Endothelial anthrax toxin receptor 2 plays a protective role in liver fibrosis. [PDF]

open access: yesFront Cell Dev Biol, 2023
Huang X   +7 more
europepmc   +1 more source

Multiple stages of evolutionary change in anthrax toxin receptor expression in humans. [PDF]

open access: yesNat Commun, 2021
Choate LA   +7 more
europepmc   +1 more source

Thermodynamic Stability Is a Strong Predictor for the Delivery of DARPins to the Cytosol via Anthrax Toxin. [PDF]

open access: yesPharmaceutics, 2021
Becker L   +4 more
europepmc   +1 more source

Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1. [PDF]

open access: yesWorld J Gastrointest Oncol, 2021
Sun KR   +5 more
europepmc   +1 more source

CRISPA: A Non-viral, Transient Cas9 Delivery System Based on Reengineered Anthrax Toxin. [PDF]

open access: yesFront Pharmacol, 2021
Hirschenberger M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy